If you track on what’s happening in downtown Portland, the name Jeff Swickard will be familiar. The new owner of Big Pink (and a number of other buildings downtown) has been on a buying spree to help rejuvenate the Rose City. And while snapping up buildings is indeed helpful, you may have been hopeful that some of that capital hit closer to home. Maybe he’ll start investing in startups, you thought…? Well, wish granted. Swickard has become an investor in Araceli Biosciences.
Not familiar with Araceli…?
Araceli Biosciences develops high-performance cellular imaging platforms designed to help researchers generate scalable, reproducible biological data for drug discovery and advanced screening applications. Founded in 2020 and spun out of Phoseon Technology in 2023, the company is headquartered in Tigard, Oregon, where most of its roughly 30 employees are based. Araceli’s Endeavor® platform and AI-driven analysis software are used by pharmaceutical and biotechnology customers across North America and Europe.
“We are excited to join an impressive group of investors in Araceli Biosciences, an innovative Oregon company developing technology with the potential to modernize scientific research and reduce the need for animal testing. We believe the future of science should be smarter, faster, and more humane. That future is already taking shape in Oregon, and we’re proud to be part of it,” said Jeff Swickard.
Total investment for this round was $4.5 million. The money will be used for “‘phase two’ of its commercialization: launching consumable products optimized for its growing installed base, with a broader rollout planned for 2027.”
For more information, visit Araceli Biosciences.
Silicon Florist on Patreon
Join 138 patrons supporting Portland startup coverage
Want even more?Includes an absolutely and totally FREE tier
